The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I, multi-center, open-label, dose-escalation study of pasireotide LAR (PAS) in patients with advanced neuroendocrine tumors (NET).
 
Jonathan R. Strosberg
Honoraria - Novartis
Consulting or Advisory Role - Lexicon; Novartis
Speakers' Bureau - Genentech; Ipsen
Research Funding - Novartis; Pharmacyclics
 
Jennifer A. Chan
Stock and Other Ownership Interests - Merck
Consulting or Advisory Role - Bayer (I); Ipsen; Novartis; Pfizer (I); POZEN (I)
Research Funding - Novartis; Sanofi
 
Alain C. Mita
Speakers' Bureau - Genentech
 
Madan Kundu
Employment - Novartis
 
Sue-zette Valera
Employment - Novartis
 
Peter Unge
Employment - Novartis
 
Christelle Darstein
Employment - Novartis
 
Mike Hu
Employment - Novartis
 
Edward M. Wolin
Consulting or Advisory Role - Celgene; Ipsen; Novartis
 
James C. Yao
Consulting or Advisory Role - Eisai; Ipsen; Merck; Novartis
Research Funding - Advanced Accelerator Applications (Inst); Novartis (Inst)